SP Tulsian discusses with Anuj Singhal and Surabhi Upadhyay his analysis on the fundamental side of the market as well as specific stocks and sectors.

Long-term investors can continue holding Aurobindo Pharma as it is the cheapest pharma stock available, said SP Tulsian.

If you take an estimated EPS of Rs 42-43 for FY19, probably this is the cheapest pharmaceutical stock available and the long-term investors those who have been holding, can look to buy again on a dip of about Rs 30-35 which you may be able to see again at a level of Rs 760, Tulsian said.

"Yesterday (Thursday) I had said that one can look for an upside of about 5-6 percent and that 5-6 percent works out maybe at about Rs 750-760," he said. "Now we are seeing the stock has moved to a level of Rs 830-835 and now ruling at Rs 805-810. So definitely we have been advising profit booking at or above Rs 800.”

Disclaimer:

The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.